Central European Life Sciences Conference Concludes Successfully in Kraków, Highlighting Regional Innovation and Investment Momentum

Kraków, Poland – 30–31 October 2025 – The 12th Central European Life Sciences Conference (LSBC 2025) concluded with resounding success, bringing together leading investors, entrepreneurs, and scientists from across Europe. Held under the theme “DNA of Capital – Cracking the Code of Life Science Investment in Volatile Times”, the event showcased the resilience, creativity, and investment potential of the European biotechnology and healthcare sectors.

BBI Cambridge, a global leader in executive education for the life sciences sector, participated prominently as Platinum Sponsor of the LSBC Pitch Competition, reinforcing its commitment to fostering leadership, entrepreneurship, and innovation in Central and Eastern Europe. Throughout the conference, BBI Cambridge representatives engaged with start-ups, investors, and industry leaders, supporting business development and exploring strategic partnerships across the region.

A Forum for Insight, Collaboration, and Regional Development

Over two days of interactive sessions, panels, and networking activities, participants explored how science, investment capital, and entrepreneurship can align to build a more connected and competitive life sciences ecosystem in Central and Eastern Europe.

The conference opened with plenary discussions on current investment trends, examining how life sciences companies are navigating economic volatility and fostering long-term sustainable growth. Panels highlighted venture-building models, mentorship programmes, and the importance of cross-border collaboration, with a focus on developing the life sciences ecosystems in Central and Eastern European countries.

Investor and start-up sessions reflected on operational and financial challenges faced by early-stage ventures, emphasising the importance of trust between scientific founders and investment partners. The role of public-private funding cooperation was also explored, identifying opportunities for strategic synergy and business growth across the region.

Innovation and Entrepreneurship in Focus

The second day of LSBC 2025 was dedicated to innovation and entrepreneurship, featuring company presentations and the regional pitch competition. Ventures showcased a diverse range of projects, including diagnostic tools, therapeutic platforms, digital health solutions, and AI-driven technologies, reflecting the dynamic evolution of the regional start-up ecosystem.

Pikralida was announced as the winner of the 2025 LSBC Pitch Competition, recognised for its innovative approach and potential to make a significant impact on global healthcare. As part of its Platinum Sponsorship, BBI Cambridge awarded the winning company a full scholarship to its International Executive MBA in Life Sciences, providing access to a global network of industry leaders and a platform for further international business development.

Complementary sessions examined emerging technologies, including drug discovery platforms, medical devices, artificial intelligence, and digital health, as well as strategies for achieving market traction in Western Europe. An additional report offered insights into the biotechnology and medical workforce landscape, covering salaries, career development, and employment trends in Poland.

Advancing Central and Eastern Europe’s Life Sciences Ecosystems

BBI Cambridge’s active participation in LSBC 2025 highlighted its ongoing commitment to supporting the growth and professional development of the life sciences sector in Central and Eastern Europe. By engaging with start-ups, investors, and research institutions, BBI Cambridge is fostering innovation, enabling leadership development, and facilitating strategic business opportunities across the region.

The successful conclusion of LSBC 2025 confirmed the conference’s status as a leading forum for dialogue, collaboration, and investment in Central and Eastern Europe, reinforcing the region’s vital role in the global life sciences community.

About LSBC

Life Sciences Biznes Consulting (LSBC) is an international organisation dedicated to promoting innovation, investment, and collaboration within the life sciences sector across Central and Eastern Europe. Through conferences, networking platforms, and strategic partnerships, LSBC connects scientists, entrepreneurs, investors, and policymakers to drive sustainable growth in biotechnology, healthcare, and related industries.

For more information, visit: www.pe-lsbc2025.pl